Evidence map›Paper›PMID 28638857›Full record

ArticleTobacco regulatory science2017

Development of the FDA Tobacco Credibility Scale (FDA-TCS).

Allison M Schmidt, Leah M Ranney, Seth M Noar, Adam O Goldstein

Abstract read
In one paragraph

Article in Tobacco regulatory science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Cigarette Constituent Health Communications for Smokers: Impact of Chemical, Imagery, and Source.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Article
  4. Public Knowledge and Credibility Perceptions of the FDA as a Tobacco Regulator.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Allison M SchmidtPhD Candidate, Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Leah M RanneyAssociate Director, Tobacco Prevention and Evaluation Program, Department of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Seth M NoarProfessor, School of Media and Journalism, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Adam O GoldsteinProfessor, Department of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Funding

Training & Education Program p294-308P50CA180907 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RIBISL, KURT M. · 2013 to 2017
$20.2M
NCI NIH HHS P50 CA180907
6 · The paper itself

Abstract

objectivesMessages from organizations with high, compared to low, credibility may be more persuasive. Whereas the tobacco industry has long recognized the importance of credibility in promoting its messages and public image, the source credibility of key tobacco control organizations has gone largely unmeasured. To assess credibility of a key tobacco regulator, we developed a scale of the US Food and Drug Administration (FDA) tobacco-related credibility.

methodsWe developed and tested 30 items reflective of the dimensions of source credibility (trust, expertise, and public interest) and FDA's tobacco regulatory roles in a sample of 1353 US adults and assessed reliability and validity.

resultsFactor analysis identified 3 dimensions of the FDA Tobacco Credibility Scale (FDA-TCS): public interest, trust, and expertise. The 3 subscales showed evidence of reliability and convergent validity; all subscales were correlated with general FDA credibility and trust in government. Those who knew that the FDA regulates tobacco scored higher on the trust and expertise subscales. The subscales were also associated with support for potential regulations, suggesting criterion-related validity.

conclusionsThe FDA-TCS allows for an understanding of the impact of credibility on responses to the FDA's tobacco control communications and regulatory efforts.

Indexed as

health communicationpublic opinionscale developmentsource credibility

Identifiers

PMID28638857
PMCPMC5476309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.